SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001247741-06-000014
Filing Date
2006-03-02
Accepted
2006-03-02 14:56:46
Documents
1
Period of Report
2006-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5880
  Complete submission text file 0001247741-06-000014.txt   7727
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address 8585507577
CROSS ALEXANDER D (Reporting) CIK: 0001182619 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20720 | Film No.: 06659424